menu ☰
menu ˟

[Editorial] The GAVI Alliance—successes and ongoing challenges

19 Oct 2013

GAVI's Mid-Term Review, published on Oct 14, examines the organisation's progress midway through the period 2011–15. It notes that by 2014, 73 countries with GAVI's support will introduce five-in-one pentavalent vaccines, including fragile states—Haiti, Burma, Somalia, and South Sudan. The costs of new, priority vaccines, such as those targeting pneumococcal and rotaviral infections, are falling owing to GAVI's efforts. Countries are graduating from GAVI support to self-financing of vaccines, and provision of new vaccines to those most in need is speeding up.

Date: 
19 October 2013

Click here to view the full article which appeared in The Lancet